Results 221 to 230 of about 30,877 (270)

First derivative synchronous spectrofluorimetric analysis of bisoprolol fumarate and ivabradine in pharmaceutical and biological matrices. Investigation of the method greenness.

Luminescence (Chichester, England Print), 2022
A novel, facile, rapid, and precise synchronous spectrofluorimetric method was evolved for the simultaneous estimation of bisoprolol fumarate and ivabradine in dosage forms and biological fluids.
Shrouk M Abo Elkheir, A. Zeid, J. Nasr, M. Walash   +3 more
semanticscholar   +1 more source

Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

Cardiovascular Drugs and Therapy, 2021
Bisoprolol and nebivolol are highly selective β 1 -adrenoceptor antagonists, with clinical indications in many countries within the management of heart failure with reduced left ventricular ejection fraction (HFrEF), ischaemic heart disease (IHD), and ...
W. AlHabeeb, Sanaa Mrabeti, A. Abdelsalam   +2 more
exaly   +2 more sources

Bisoprolol

Reactions Weekly, 2022
  +9 more sources

Accelerated Stability Indicating LC Method for Simultaneous Quantification of Dapagliflozin Propanediol Monohydrate and Bisoprolol Fumarate

Separation Science Plus
A combination of dapagliflozin propanediol monohydrate and bisoprolol fumarate was approved by a regulatory agency for the treatment of Type 2 diabetes mellitus in patients with hypertension.
Gopal Valiya, Hetaben Kachhiya, Ruturaj Sutarsandhiya, Riddhi Patel, Jinal N Tandel, U. Chhalotiya, Dimalkumar S. Shah   +6 more
semanticscholar   +1 more source

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.

Journal of the American Medical Association (JAMA)
Importance Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Observational studies report that β-blocker use may be associated with reduced risk of COPD exacerbations.
Graham Devereux, S. Cotton, Mintu Nath, N. McMeekin, Karen Campbell, Rekha Chaudhuri, G. Choudhury, A. De Soyza, S. Fielding, S. Gompertz, J. Haughney, Amanda Lee, Graeme MacLennan, A. Morice, J. Norrie, David Price, P. Short, J. Vestbo, Paul Walker, J. Wedzicha, Andrew Wilson, Olivia Wu, B. Lipworth   +22 more
semanticscholar   +1 more source

Stability-Indicating RP-HPLC and CE Methods for Simultaneous Determination of Bisoprolol and Perindopril in Pharmaceutical Formulation: A Comparative Study.

Journal of Chromatographic Science, 2020
Two fast, accurate and selective stability-indicating methods were developed and validated for the simultaneous determination of bisoprolol, perindopril and three of their possible degradation products.
S. Hassan, Nancy W. Nashat, Mohamed R. Elghobashy, S. Abbas, A. Moustafa   +4 more
semanticscholar   +1 more source

Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: a long-term follow-up study

Journal of Cardiovascular Medicine, 2021
Aim The aim of our study was to compare ivabradine versus bisoprolol in the short-term and long-term treatment of inappropriate sinus tachycardia.
A. Martino, M. Rebecchi, Antonella Sette, F. Cicogna, A. Politano, M. Sgueglia, E. De Ruvo, M. Volterrani, L. Calò   +8 more
semanticscholar   +1 more source

Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.

Journal of Hypertension, 2020
OBJECTIVES Our aim was to evaluate the effects of beta-blockers during the second and third trimester on fetal growth, length of gestation and postnatal symptoms in exposed infants.
Angela Kayser, Evelin Beck, M. Hoeltzenbein, Sandra Zinke, R. Meister, C. Weber-Schoendorfer, C. Schaefer   +6 more
semanticscholar   +1 more source

Bisoprolol

Reactions Weekly, 2020
  +6 more sources

Bisoprolol

Reactions Weekly
  +9 more sources